Does ARIPIPRAZOLE Cause Neuroleptic malignant syndrome? 1,138 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 1,138 reports of Neuroleptic malignant syndrome have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 1.7% of all adverse event reports for ARIPIPRAZOLE.
1,138
Reports of Neuroleptic malignant syndrome with ARIPIPRAZOLE
1.7%
of all ARIPIPRAZOLE reports
134
Deaths
807
Hospitalizations
How Dangerous Is Neuroleptic malignant syndrome From ARIPIPRAZOLE?
Of the 1,138 reports, 134 (11.8%) resulted in death, 807 (70.9%) required hospitalization, and 354 (31.1%) were considered life-threatening.
Is Neuroleptic malignant syndrome Listed in the Official Label?
Yes, Neuroleptic malignant syndrome is listed as a known adverse reaction in the official FDA drug label for ARIPIPRAZOLE.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Neuroleptic malignant syndrome?
QUETIAPINE (1,756)
OLANZAPINE (1,748)
RISPERIDONE (1,258)
HALOPERIDOL (1,244)
CLOZAPINE (899)
LITHIUM (506)
LORAZEPAM (437)
PALIPERIDONE (355)
VALPROIC ACID (352)
SERTRALINE (309)
Which ARIPIPRAZOLE Alternatives Have Lower Neuroleptic malignant syndrome Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE